Physician profile
Thomas Benjamin Arnold
NPI 1982695011
$6,245.82
in general payments reported to CMS, 2019-2025
25 companies · $686 in 2025
The $686 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $289 · 2021: $1,591 · 2022: $829 · 2023: $888 · 2024: $1,338 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,911.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,428.21 | 2019-2025 | Grafix Pl, Renasys Go V2 Home, Pico |
| Treace Medical Concepts, INC. | $1,054.03 | 2021-2025 | |
| Organogenesis INC. | $741.87 | 2019-2025 | Puraply, Apligraf, Puraply Am |
| Stryker Corporation | $580.77 | 2019-2025 | Asnis, 7 X 23mm Citrelock Implant, Variax |
| Paratek Pharmaceuticals, INC. | $571.90 | 2021-2025 | Nuzyra |
| Kerecis Limited | $266.58 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $220.84 | 2024-2025 | Krystexxa |
| Nevro Corp. | $206.97 | 2022-2024 | Senza |
| Mimedx Group, INC. | $132.75 | 2025 | |
| Convatec INC. | $128.50 | 2024 | |
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Amniox Medical, INC. | $124.94 | 2020 | |
| Abbvie INC. | $121.34 | 2021 | |
| Orthofix Medical, INC. | $118.96 | 2024 | Physio-Stim |
| Kci USA, INC. | $118.53 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $90.50 | 2021-2024 | |
| Boston Scientific Corporation | $60.17 | 2022 | |
| Integra Lifesciences Corporation | $36.35 | 2019 | |
| Zimmer Biomet Holdings, INC. | $24.23 | 2019 | |
| Paragon 28, INC. | $18.77 | 2023 | Mtp |
| Arteriocyte Medical Systems, INC. | $18.30 | 2025 | Magellan |
| Acell, INC. | $16.02 | 2020 | |
| Nexus Medical Technologies LLC | $15.25 | 2025 | |
| Osiris Therapeutics INC. | $13.11 | 2019 | |
| Highridge Medical LLC | $11.94 | 2024 | Biomet Ebi Bone Healing System, Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.